Deutsche Bank’s Evogene EVGN Stock Holding History

Deutsche Bank’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-800	Closed	-$25K	–	5214
2018 Q3	$25K	Buy	800 +770	+2,567%	+$22.3K	﹤0.01%	4887
2018 Q2	$1K	Sell	30 -608	-95%	-$18.5K	﹤0.01%	5338
2018 Q1	$20K	Sell	638 -172	-21%	-$6.41K	﹤0.01%	4992
2017 Q4	$24K	Buy	810 +800	+8,000%	+$31.4K	﹤0.01%	4625
2017 Q3	$0	Buy	+10	New	+$476	﹤0.01%	4936
2016 Q2	–	Sell	-155	Closed	-$10K	–	5223
2016 Q1	$10K	Buy	+155	New	+$10.6K	﹤0.01%	4827

Other funds holding EVGN

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Deutsche Bank's EVGN Position: Q4 2018 in Review

Deutsche Bank sold out of Evogene (EVGN) in Q4 2018, closing a stake of 800 shares — an estimated $25K sold.

Deutsche Bank first reported a position in EVGN in Q1 2016 and held it in 6 quarters. The position peaked at $25K in Q3 2018. 23 funds tracked by Wall St. Rank hold EVGN as of Q4 2018.

Deutsche Bank reported no remaining Evogene position as of Q4 2018 after selling out during the quarter.
Deutsche Bank sold 800 Evogene shares in Q4 2018, an estimated $25K.
Deutsche Bank first reported a position in Evogene in Q1 2016 and held it in 6 quarters.
Deutsche Bank's Evogene position peaked at $25K in Q3 2018.
23 funds tracked by Wall St. Rank held Evogene as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.